US Patent Issued to Idorsia Pharmaceuticals on Jan. 27 for "Stable crystalline hydrate of clazosentan disodium salt" (Swiss Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,449, issued on Jan. 27, was assigned to Idorsia Pharmaceuticals Ltd (Allschwil, Switzerland).

"Stable crystalline hydrate of clazosentan disodium salt" was invented by Timo Rager (Allschwil, Switzerland) and Markus Von Raumer (Allschwil, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a stable hydrate of clazosentan disodium salt, pharmaceutical formulations manufactured using the same and their use as medicaments."

The patent was filed on Nov. 4, 2021, under Application No. 18/251,814.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?...